Asker mutually agreed to discontinue acquisition of Hardam
The deal, announced in June 2025, was mutually terminated after a long closing process; Asker now focuses on other acquisition targets.
See the latest news and media coverage for Asker. We track all announcements, press releases, and industry mentions in real time, all in one place.
European healthcare group providing medical products and solutions
asker.comLast updated
In short: Asker Healthcare Group grew through acquisitions and a Nasdaq listing, but recently discontinued its planned purchase of Kirstine Hardam.
The deal, announced in June 2025, was mutually terminated after a long closing process; Asker now focuses on other acquisition targets.
The AGM adopts financial statements, approves SEK 0.39 dividend, re-elects and elects board members including Mikael Stöhr as Chair, and resolves on share program and authorizations.
The interim report publishes on 6 May 2026 at 08:10 CEST, with presentation at 10:00 CEST by CEO and CFO, followed by Q&A.
CEO Johan Falk highlights 17% EBITA growth, Nasdaq listing, 14 acquisitions, and entry into four new countries. The report is available at asker.com.
Asker Healthcare Group reported a robust second quarter for 2025, with net sales rising 9% to 4 billion SEK and an adjusted EBITDA...
Asker Healthcare Group and KMT Medical Europe, the owner of Kirstine Hardam, have agreed to discontinue the transaction of Hardam that was announced in June...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...
Information Services Group (NASDAQ:III) reported first-quarter 2026 results that landed at the top...
Track Asker and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.